NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization
-
Published:2019
Issue:6
Volume:8
Page:491-504
-
ISSN:2235-1795
-
Container-title:Liver Cancer
-
language:en
-
Short-container-title:Liver Cancer
Author:
Schotten Clemens, Bechmann Lars P., Manka Paul, Theysohn Jens, Dechêne Alexander, El Fouly Amr, Barbato Francesco, Neumann Ursula, Radünz Sonia, Sydor Svenja, Heider Dominik, Venerito Marino, Canbay AliORCID, Gerken Guido, Herrmann Ken, Wedemeyer Heiner, Best Jan
Subject
Oncology,Hepatology
Reference38 articles.
1. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011 Sep;365(12):1118–27. 2. White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol 2012;10:1342–59. e1342. 3. Ertle J, Dechêne A, Sowa JP, Penndorf V, Herzer K, Kaiser G, et al. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer. 2011 May;128(10):2436–43. 4. Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2012 Apr;56(4):952–64. 5. El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol. 2001 Aug;96(8):2462–7.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|